boustead spore - BSTGF

BSTGF

Close Chg Chg %
0.00 0.00 0.00%

Pre-Market

0.00

0.00 (0.00%)

Volume: 100.00

Last Updated:

Nov 3, 2025, 11:04 AM EDT

Company Overview: boustead spore - BSTGF

BSTGF Key Data

Open

$0.00

Day Range

0.00 - 0.00

52 Week Range

0.00 - 0.00

Market Cap

N/A

Shares Outstanding

504.72M

Public Float

245.35M

Beta

-1.98

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

$0.05

Yield

N/A

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

BSTGF Performance

No Data Available

BSTGF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About boustead spore - BSTGF

Boustead Singapore Ltd. operates as an investment holding company. The firm engages in the engineering and development of infrastructures. It operates through the following segments: Energy-Related Engineering, Real Estate Solutions, Geo-Spatial Technology, Healthcare technology and HQ Activities. The Energy-Related Engineering segment relates to the design, engineering, and supply of systems to the oil and gas, petrochemical, and solid waste energy recovery sectors. The Real Estate Solutions segment includes the provision of design and builds expertise for industrial facilities and design, building and lease arrangements for industrial facilities. The Geo-Spatial Technology segment specializes in Esri geographic information systems and location intelligence. The Healthcare technology segment engages in distribution and services related to niche medical solutions that address age-related chronic diseases and mobility issues, with a focus on rehabilitative care, sleep care sports science in the Asia Pacific. The HQ Activities segment manages the investment portfolio to maximize shareholders' returns. The company was founded by Edward Boustead in 1828 and is headquartered in Singapore.

BSTGF At a Glance

Boustead Singapore Ltd.
Edward Boustead Centre
Singapore, Central Singapore 408832
Phone 65-6747-0016 Revenue 484.35M
Industry Engineering & Construction Net Income 180.41M
Sector Industrial Services 2026 Sales Growth 22.965%
Fiscal Year-end 03 / 2027 Employees N/A
View SEC Filings

BSTGF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

BSTGF Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 2.711
Total Asset Turnover 0.546

BSTGF Liquidity

Current Ratio 1.755
Quick Ratio 1.749
Cash Ratio 0.944

BSTGF Profitability

Gross Margin 34.525
Operating Margin 12.135
Pretax Margin 34.391
Net Margin 37.248
Return on Assets 20.352
Return on Equity 34.52
Return on Total Capital 26.641
Return on Invested Capital 33.234

BSTGF Capital Structure

Total Debt to Total Equity 10.524
Total Debt to Total Capital 9.522
Total Debt to Total Assets 6.704
Long-Term Debt to Equity 3.179
Long-Term Debt to Total Capital 2.876
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Boustead Spore - BSTGF

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
408.74M 570.75M 393.89M 484.35M
Sales Growth
-12.77% +39.63% -30.99% +22.96%
Cost of Goods Sold (COGS) incl D&A
294.45M 402.15M 219.67M 317.13M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
7.26M 8.29M 6.61M 7.17M
Depreciation
7.26M 6.23M 6.49M 7.05M
Amortization of Intangibles
4.37K 2.07M 118.82K 124.88K
COGS Growth
-18.47% +36.57% -45.38% +44.36%
Gross Income
114.29M 168.60M 174.22M 167.22M
Gross Income Growth
+6.39% +47.52% +3.33% -4.02%
Gross Profit Margin
+27.96% +29.54% +44.23% +34.52%
2023 2024 2025 2026 5-year trend
SG&A Expense
80.24M 101.14M 100.34M 108.45M
Research & Development
- - - -
-
Other SG&A
80.24M 101.14M 100.34M 108.45M
SGA Growth
-1.21% +26.05% -0.79% +8.08%
Other Operating Expense
- - - -
-
Unusual Expense
(382.08K) 720.53K 1.21M (1.25M)
EBIT after Unusual Expense
34.43M 66.74M 72.67M 60.03M
Non Operating Income/Expense
24.00M 17.78M 35.58M 108.82M
Non-Operating Interest Income
9.55M 13.84M 15.05M 14.04M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
2.28M 1.23M 1.74M 2.27M
Interest Expense Growth
+57.28% -46.14% +42.00% +30.66%
Gross Interest Expense
2.28M 1.23M 1.74M 2.27M
Interest Capitalized
- - - -
-
Pretax Income
56.16M 83.29M 106.50M 166.57M
Pretax Income Growth
+83.26% +48.32% +27.86% +56.40%
Pretax Margin
+13.74% +14.59% +27.04% +34.39%
Income Tax
14.76M 21.03M 17.37M 20.60M
Income Tax - Current - Domestic
- 15.26M 21.65M 1.62M
Income Tax - Current - Foreign
- - - 16.34M
-
Income Tax - Deferred - Domestic
- (505.07K) (617.91K) (585.12K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
40.90M 53.66M 74.79M 183.26M
Minority Interest Expense
7.91M 5.93M 3.76M 2.85M
Net Income
32.99M 47.73M 71.03M 180.41M
Net Income Growth
+45.48% +44.69% +48.81% +154.00%
Net Margin Growth
+8.07% +8.36% +18.03% +37.25%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
32.99M 47.73M 71.03M 180.41M
Preferred Dividends
- - - -
-
Net Income Available to Common
32.99M 47.73M 71.03M 180.41M
EPS (Basic)
0.0687 0.1 0.1462 0.3614
EPS (Basic) Growth
+46.48% +45.56% +46.20% +147.20%
Basic Shares Outstanding
480.24M 477.47M 485.73M 499.26M
EPS (Diluted)
0.0687 0.1 0.1462 0.3614
EPS (Diluted) Growth
+46.48% +45.56% +46.20% +147.20%
Diluted Shares Outstanding
480.24M 477.47M 485.73M 499.26M
EBITDA
41.31M 75.75M 80.49M 65.95M
EBITDA Growth
+18.80% +83.37% +6.25% -18.07%
EBITDA Margin
+10.11% +13.27% +20.43% +13.62%

Boustead Spore in the News